Philips stock holds steady after latest NYSE close
Published on 08/22/2026 at 09:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Koninklijke Philips N.V. (ISIN NL0000009538) stock has been trading steadily on the NYSE, with the most recent regular-session close of $27.50 on August 20, 2026, and a modest overnight uptick to $27.60 reported in off-hours trading on August 21, 2026.
Recent trading levels and valuation context
Per a same-day market-data overview for the PHG ticker, Philips shares last closed at $27.50 on August 20, 2026, down $0.12 or 0.43 percent for that session, while an overnight indication showed $27.60, implying a 0.36 percent move outside regular NYSE hours as of August 21, 2026.
That price level places Philips at a market capitalization that aligns with its profile as a global health-technology supplier, and the modest day-over-day fluctuations underline a stable trading pattern rather than a sharp rerating at this stage.
Latest reported financial performance
Recent coverage of Philips highlights the company’s most current financial figures from its latest reported quarter in 2026, where management has focused on improving profitability in its diagnosis and treatment, connected care, and personal health businesses.
In that latest 2026 reporting period, Philips reported revenue growth and an increase in earnings compared with the prior year’s comparable quarter, underscoring ongoing progress in operational efficiency and cost control while continuing to invest in innovation and regulatory compliance for its medical-technology portfolio.
The company’s current guidance framework for 2026 targets continued comparable sales growth and margin improvement versus 2025, with management citing its order backlog in hospital equipment and its installed base of connected devices as key drivers for free cash flow and debt reduction.
Analyst and consensus view in 2026
Recent analyst overviews compiled in August 2026 point to a consensus that Philips should deliver mid-single-digit comparable sales growth for the full year 2026, along with an improvement in adjusted EBITA margins compared with the previous year.
Compared with earlier expectations in 2025, that consensus now reflects a more constructive view of Philips ability to stabilize its sleep and respiratory care activities and to leverage higher-margin enterprise informatics offerings, even as the broader health-care capital spending environment remains disciplined.
For investors, the key quantified comparison in these views is the projected uplift in margins and earnings per share versus 2025, which, if achieved, would support a gradual re-rating of the stock rather than a rapid move.
Health technology portfolio and product focus
Beyond the numbers, Philips continues to emphasize its health-technology solutions spanning imaging systems, patient monitoring, and consumer health devices designed to support more efficient and personalized care.
A representative example is its diagnostic imaging systems, which combine hardware and software to help clinicians detect and monitor disease earlier and more accurately, while integrating with hospital information systems to streamline workflows.
Alongside professional equipment, Philips maintains a broad range of consumer health products, such as oral-care and personal-care devices, that feed into its brand recognition and cash-generation capabilities, complementing the more cyclical capital equipment businesses.
Shares and as-of price context
Philips stock trades on the NYSE under the PHG ticker, with the most recently evidenced regular-session close of $27.50 per share as of August 20, 2026, 4:00 p.m. ET; the overnight indication of $27.60 as of August 21, 2026, reflects off-hours liquidity but does not represent a completed main-session close.
Fact box
Company: Koninklijke Philips N.V.
ISIN: NL0000009538
Ticker: PHG
Exchange: NYSE
Price (as of August 20, 2026, 4:00 p.m. ET): $27.50 USD
Sector / Industry: Health technology / Medical equipment and devices
Index membership: Euro Stoxx and related European indices
